Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ran Tur-Kaspa

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Harefuah|February 3, 2006
[Medical students' reactions to their experience in oncology and its contribution to their training]Netta Notzer, Ran Tur-Kaspa
Journal of Clinical Gastroenterology|November 3, 2009
Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acidRawi Hazzan, Ran Tur-Kaspa
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Chronic hepatitis C virus infection in older adultsEsther-Lee Marcus, Ran Tur-Kaspa
Clinics in Liver Disease|June 22, 2011
The role of oncogenic viruses in the pathogenesis of hepatocellular carcinomaRomy Zemel, Assaf Issachar, Ran Tur-Kaspa
Cancers|November 27, 2024
Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling PathwaysNarmen Esmael, Ido Lubin, Ran Tur-Kaspa, et al.
The New England Journal of Medicine|March 3, 2006
Clinical problem-solving. Search for the complicationFrancis Salamon, Rafael Hirsch, Ran Tur-Kaspa, et al.
The Israel Medical Association Journal : IMAJ|July 14, 2005
Inflammatory pseudotumor of the liver: a therapeutic dilemmaMichal Cohen, David Huminer, Francis Salamon, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationLior H Katz, Ran Tur-Kaspa, Daniel G Guy, et al.
Journal of Clinical Gastroenterology|June 18, 2003
Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infectionHemda Schmilovitz-Weiss, Ehud Melzer, Ran Tur-Kaspa, et al.
Journal of Hepatology|May 26, 2004
Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodiesRomy Zemel, Yevgeny Berdichevsky, Larisa Bachmatov, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Harefuah|February 3, 2006
[Medical students' reactions to their experience in oncology and its contribution to their training]Netta Notzer, Ran Tur-Kaspa
Journal of Clinical Gastroenterology|November 3, 2009
Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acidRawi Hazzan, Ran Tur-Kaspa
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2005
Chronic hepatitis C virus infection in older adultsEsther-Lee Marcus, Ran Tur-Kaspa
Clinics in Liver Disease|June 22, 2011
The role of oncogenic viruses in the pathogenesis of hepatocellular carcinomaRomy Zemel, Assaf Issachar, Ran Tur-Kaspa
Cancers|November 27, 2024
Hepatitis B Virus-Induced Resistance to Sorafenib and Lenvatinib in Hepatocellular Carcinoma Cells: Implications for Cell Viability and Signaling PathwaysNarmen Esmael, Ido Lubin, Ran Tur-Kaspa, et al.
The New England Journal of Medicine|March 3, 2006
Clinical problem-solving. Search for the complicationFrancis Salamon, Rafael Hirsch, Ran Tur-Kaspa, et al.
The Israel Medical Association Journal : IMAJ|July 14, 2005
Inflammatory pseudotumor of the liver: a therapeutic dilemmaMichal Cohen, David Huminer, Francis Salamon, et al.
The Cochrane Database of Systematic Reviews|July 9, 2010
Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantationLior H Katz, Ran Tur-Kaspa, Daniel G Guy, et al.
Journal of Clinical Gastroenterology|June 18, 2003
Excellent outcome of Lamivudine treatment in patients with chronic renal failure and hepatitis B virus infectionHemda Schmilovitz-Weiss, Ehud Melzer, Ran Tur-Kaspa, et al.
Journal of Hepatology|May 26, 2004
Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodiesRomy Zemel, Yevgeny Berdichevsky, Larisa Bachmatov, et al.
Pageof 5